Literature DB >> 6134548

Urticaria and vasculitis: a continuum of histological and immunopathological changes.

R R Jones, B Bhogal, A Dash, J Schifferli.   

Abstract

Histopathological criteria were used to classify twenty-four patients with chronic urticaria into three groups, which were then studied to establish whether circulating immune complexes (CICs), complement activation and deposition of immunoreactants are confined to patients with urticarial vasculitis. Group I (three patients) had classical urticarial vasculitis, and two of these patients showed hypocomplementaemia with evidence of C3 conversion and deposition of immunoreactants in lesional and uninvolved skin. Ten patients (group 2) with a dense perivascular mixed-cellular infiltrate had normal or raised complement levels and infrequent evidence of C3 conversion. Immunoreactants were detected only in their lesional skin. Eleven patients (group 3) had only a sparse perivascular infiltrate. In this group, complement was normal and immunofluorescence was essentially negative. Cryoglobulins were detected in group I patients only. Monoclonal rheumatoid factor and C1q binding were positive in all group I patients, half the group 2 patients and none of the group 3 patients. This study suggests that urticaria and urticarial vasculitis form a disease continuum, and identifies a group of patients with features intermediate between urticarial vasculitis and ordinary urticaria.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6134548     DOI: 10.1111/j.1365-2133.1983.tb01082.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  9 in total

1.  Urticaria and vasculitis: a vascular spectrum of disease.

Authors:  B Lycka
Journal:  Can Fam Physician       Date:  1987-05       Impact factor: 3.275

Review 2.  Hypocomplementemic urticarial vasculitis syndrome: an interdisciplinary challenge.

Authors:  Wolfgang Grotz; Hideo A Baba; Jan U Becker; Martin W Baumgärtel
Journal:  Dtsch Arztebl Int       Date:  2009-11-13       Impact factor: 5.594

Review 3.  Histopathology of chronic urticaria.

Authors:  G Edward Stewart
Journal:  Clin Rev Allergy Immunol       Date:  2002-10       Impact factor: 8.667

Review 4.  Urticarial vasculitis.

Authors:  Joe Venzor; Wai L Lee; David P Huston
Journal:  Clin Rev Allergy Immunol       Date:  2002-10       Impact factor: 8.667

Review 5.  [Urticaria and antihistamines].

Authors:  J Tousignant; B Côté; D Barolet
Journal:  Can Fam Physician       Date:  1993-01       Impact factor: 3.275

6.  Plasmapheresis in a patient with "refractory" urticarial vasculitis.

Authors:  Ozgur Kartal; Mustafa Gulec; Zafer Caliskaner; Oral Nevruz; Turker Cetin; Osman Sener
Journal:  Allergy Asthma Immunol Res       Date:  2012-03-14       Impact factor: 5.764

7.  A novel histopathological scoring system to distinguish urticarial vasculitis from chronic spontaneous urticaria.

Authors:  Viktoria Puhl; Hanna Bonnekoh; Jörg Scheffel; Tomasz Hawro; Karsten Weller; Peter von den Driesch; Hans-Joachim Röwert-Huber; José Cardoso; Margarida Gonçalo; Marcus Maurer; Karoline Krause
Journal:  Clin Transl Allergy       Date:  2021-04       Impact factor: 5.871

8.  Urticarial vasculitis in northern Spain: clinical study of 21 cases.

Authors:  Javier Loricera; Vanesa Calvo-Río; Cristina Mata; Francisco Ortiz-Sanjuán; Marcos A González-López; Lino Alvarez; M Carmen González-Vela; Susana Armesto; Héctor Fernández-Llaca; Javier Rueda-Gotor; Miguel A González-Gay; Ricardo Blanco
Journal:  Medicine (Baltimore)       Date:  2014-01       Impact factor: 1.889

9.  Patient-reported outcomes in urticarial vasculitis treated with omalizumab: case report.

Authors:  Ivan Cherrez-Ojeda; Emanuel Vanegas; Miguel Felix; Valeria L Mata; Annia Cherrez
Journal:  BMC Dermatol       Date:  2018-10-25
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.